Vytrus Biotech S.A. (VYT) — Capital Reinvestment Ratio
Latest as of December 2022:
2.19x
Vytrus Biotech S.A. (VYT) has a Capital Reinvestment Ratio of 2.19x as of December 2022, meaning it reinvests 2% of its operating cash flow (€225.55K) in capital expenditures (€494.16K). See VYT FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
2.19x
Capex / Operating Cash Flow
Operating Cash Flow
€225.55K
EUR
Capital Expenditures
€494.16K
EUR
Data as of
Dec 2022
Most recent filing
Vytrus Biotech S.A. Capital Reinvestment Ratio (2021–2025)
This chart tracks Vytrus Biotech S.A.'s Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for Vytrus Biotech S.A. (2021–2025)
Year-by-year Capital Reinvestment Ratio for Vytrus Biotech S.A. from 2021 to 2025. For live market cap and broader valuation context, see Vytrus Biotech S.A. stock valuation.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.69x | €3.90 Million | €2.68 Million | ▲ +5.2% |
| 2024 | 0.65x | €1.84 Million | €1.20 Million | ▼ -49.4% |
| 2023 | 1.29x | €904.39K | €1.17 Million | ▼ -41.1% |
| 2022 | 2.19x | €225.55K | €494.16K | ▲ +261.0% |
| 2021 | 0.61x | €447.92K | €271.82K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow